| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
in00005762011 |
| 005 |
20260327152031.7 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
170603s2018 paua ob 001 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e rda
|e pn
|c EBLCP
|d OCLCQ
|d YDX
|d N$T
|d OCLCF
|d OPELS
|d OCLCQ
|d U3W
|d CUV
|d AU@
|d OCLCQ
|d OCLCO
|d S2H
|d OCLCO
|d LVT
|d OCLCA
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d SXB
|d OCLCQ
|
| 019 |
|
|
|a 988292750
|a 988325967
|a 1229796306
|
| 020 |
|
|
|a 9780323496087
|q (electronic bk.)
|
| 020 |
|
|
|a 0323496083
|q (electronic bk.)
|
| 020 |
|
|
|z 9780323485678
|
| 020 |
|
|
|z 0323485677
|
| 035 |
|
|
|a (OCoLC)988868475
|z (OCoLC)988292750
|z (OCoLC)988325967
|z (OCoLC)1229796306
|
| 050 |
|
4 |
|a RC270.3.D53
|
| 060 |
|
4 |
|a QZ 241
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.9940754
|2 23
|
| 049 |
|
|
|a TXAM
|
| 245 |
0 |
0 |
|a PET/CT in cancer :
|b an interdisciplinary approach to individualized imaging /
|c [edited by] Mohsen Beheshti, Werner Langsteger, Alireza Rezaee ; associate editors, Markus Raderer, Niklaus Schaeffer.
|
| 264 |
|
1 |
|a Philadelphia, PA :
|b Elsevier,
|c [2018]
|
| 300 |
|
|
|a 1 online resource :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Front Cover; PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging; PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging; Copyright; Contributors; Preface; Contents; Abbreviations; 1 -- Head and Neck Cancers; BACKGROUND; General; Early Clinical Symptoms9; Standard Diagnostic Procedures10; Standard Treatment11-13; Prognostic Factors13-15; Five-Year Survival16; TUMOR CHARACTERISTICS AND TYPICAL BEHAVIOR; Histopathology2,17; N-lymph nodes2; M-distant metastasis2; TNM CLASSIFICATION13,19; Guidelines; EVIDENCE-BASED VIEWPOINTS; COST-EFFECTIVENESS.
|
| 505 |
8 |
|
|a CLINICAL POINT OF VIEWPITFALLS31-35; False Positive; False Negative; DISCUSSION; TEACHING CASES; Case 1: Staging, Laryngeal Cancer; Case 2: Staging, SCC, Base of the Tongue; Case 3: Staging, Sinus Piriform Cancer; Case 4: Cancer of Unknown Primary; Case 5: Staging, Adenoid Cystic Carcinoma; Case 6: Staging, Tonsillar Cancer With Incidental Second Cancer; Case 7: Staging, Oropharyngeal Cancer, Myelodysplastic Syndrome; Case 8: HNSCC, Recurrence; Case 9: Therapy Monitoring, Nasopharyngeal Cancer; Case 10: Staging and Restaging Rhabdomyosarcoma; REFERENCES; 2 -- Lung Cancer; BACKGROUND; General1.
|
| 505 |
8 |
|
|a Clinical Signs/Symptoms6Primary Diagnostic Procedures7-12; Standard Treatments13-26; Non-small cell lung cancer; Prognostic Factors27-33; Non-small cell lung cancer; Small cell lung cancer; TUMOR CHARACTERISTICS AND TYPICAL BEHAVIOR; Histopathology1; N-lymph nodes; M-distant metastasis; TNM CLASSIFICATION34,35; Primary Tumor (T); Regional Lymph Nodes (N); Distant Metastasis (M); GUIDELINES; EVIDENCE-BASED VIEWPOINTS; COST-EFFECTIVENESS46,54-56; CLINICAL POINT OF VIEW; Suspected Disease; Initial Diagnosis; Non-small Cell Lung Cancer; Small Cell Lung Cancer.
|
| 505 |
8 |
|
|a Suspected Recurrence After Potentially Curative TherapyMetastatic Disease; Response to Therapy; PITFALLS57-59; False Positive; False Negative; DISCUSSION; Solitary Pulmonary Nodules; Staging Lung Cancer; Prognostic Value; Therapy Monitoring; Detection of Tumor Burden and Planning for Radiation Therapy; Comparison With Other Modalities; Radiopharmaceuticals Beyond FDG; CONCLUSION; TEACHING CASES; Case 1: Staging at SCLC; Case 2: Staging NSCLC-Early Detection of Distant Metastases; Case 3: Staging NSCLC-Atypical Distant Metastases; Case 4: Staging NSCLC-Atypical Distant Metastases.
|
| 505 |
8 |
|
|a Case 5: Staging Lung Cancer-Guiding Biopsy and RadiotherapyCase 6: Staging SCLC-Differentiation of Limited From Extended Stage; Case 7: NSCLC-Recurrence; Case 8: Mesothelioma-Treatment Monitoring; Case 9: Talc Pleurodesis; Case 10: Carcinoid Tumor-Very Low FDG-Avid Malignancies; REFERENCES; 3 -- Breast Cancer; BACKGROUND; General1,2; Early Clinical Symptoms1,3; Primary Diagnostic Procedures1,4; Standard Treatment5; Prognostic Factors6; Five-Year Survival7; TUMOR CHARACTERISTICS AND TYPICAL BEHAVIOR; Histopathology8; Distribution and Localization9-11; N-lymph nodes; T-primary.
|
| 500 |
|
|
|a M-distant metastasis.
|
| 520 |
|
|
|a Edited, authored, and reviewed by an expert team of oncologists and nuclear physicians/radiologists, this one-of-a-kind title helps you make the most of the critical role PET/CT plays in cancer staging and therapeutic responses to individualized treatments. Drs. Mohsen Beheshti, Werner Langsteger, and Alireza Rezaee place an emphasis on cutting-edge research and evidence-based practice, ensuring that you're up to date with every aspect of this fast-changing field. For each tumor entity, you'll find authoritative discussions of background, pathology, common pattern of spread, TNM classification, clinical guidelines, discussion, evidence-based recommendations, key points, and pitfalls.
|
| 650 |
|
0 |
|a Cancer
|x Imaging.
|
| 650 |
|
0 |
|a Oncology.
|
| 650 |
1 |
2 |
|a Neoplasms
|x diagnostic imaging
|
| 650 |
2 |
2 |
|a Positron Emission Tomography Computed Tomography
|x methods
|
| 650 |
2 |
2 |
|a Precision Medicine
|x methods
|
| 650 |
|
2 |
|a Medical Oncology
|
| 650 |
|
6 |
|a Cancer
|x Imagerie.
|
| 650 |
|
6 |
|a Cancérologie.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Cancer
|x Imaging
|2 fast
|
| 650 |
|
7 |
|a Oncology
|2 fast
|
| 655 |
|
7 |
|a Electronic books.
|2 local
|
| 700 |
1 |
|
|a Beheshti, Mohsen,
|e editor.
|
| 700 |
1 |
|
|a Langsteger, Werner,
|e editor.
|
| 700 |
1 |
|
|a Rezaee, Alireza,
|e editor.
|
| 710 |
2 |
|
|a ScienceDirect (Online service)
|
| 776 |
0 |
8 |
|i Print version:
|t PET/CT in cancer.
|d Philadelphia, PA : Elsevier, [2018]
|z 9780323485678
|w (OCoLC)1007679898
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=https://www.sciencedirect.com/science/book/9780323485678
|z Connect to the full text of this electronic book
|t 0
|
| 955 |
|
|
|a Elsevier ScienceDirect 2026-2027
|
| 994 |
|
|
|a 92
|b TXA
|
| 999 |
f |
f |
|i b2d02812-0383-423d-a003-f1031373ea41
|s 429b3d4c-972f-4beb-953b-0457a83394b5
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|s www_evans
|d Available Online
|t 0
|e RC270.3.D53
|h Library of Congress classification
|
| 998 |
f |
f |
|a RC270.3.D53
|t 0
|l Available Online
|